PT  - JOURNAL ARTICLE
AU  - Hiles, Guadalupe Lorenzatti
AU  - Chang, Kai-Ping
AU  - Bellile, Emily L.
AU  - Wang, Chun-I
AU  - Yen, Wei-Chen
AU  - Goudsmit, Christine M.
AU  - Briggs, Hannah L.
AU  - Thomas, Trey B.
AU  - Peters, Lila
AU  - Afsari, Macy A.
AU  - Pinatti, Lisa M.
AU  - Morris, Anna C.
AU  - Jawad, Nadine
AU  - Carey, Thomas E.
AU  - Walline, Heather M.
TI  - Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study
AID  - 10.1101/2020.10.26.20213231
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.26.20213231
4099  - http://medrxiv.org/content/early/2020/10/27/2020.10.26.20213231.short
4100  - http://medrxiv.org/content/early/2020/10/27/2020.10.26.20213231.full
AB  - Background In North America and Western Europe, human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC) has increased dramatically over the past 40 years, whereas HPV-negative OPSCC, typically associated with alcohol and tobacco as etiological factors, has declined. In Taiwan, the OPSCC rate is increasing; however, there is limited understanding of the role of HPV, as tobacco, alcohol, and betel quid use are still very prominent. Here we investigated the involvement of HPV and its prognostic implications for OPSCC in Taiwan.Methods and findings We studied a retrospective cohort of 541 OPSCCs undergoing care between 1998 and 2016 at the Chang Gung Memorial Hospital-Linkou, Taiwan. Clinical and risk exposure data were retrieved from hospital charts. Most cases were males (94%) and had concomitant (87%) exposure to alcohol (51%), tobacco (83%), and betel quid (65%). Formalin-fixed, paraffin-embedded tissue sections were immunostained for p16, a surrogate for active HPV, and DNA was tested for HPV detection and genotyping by Multiplex PCR-MassArray. Tumors with p16 and/or HPV DNA positivity were identified as HPV-positive. HPV status was assigned to 528 tumors. The prevalence of HPV-positive OPSCC was 28.4% (150/528), with a strong correlation between p16 and HPV DNA results (F < 0.0001). We observed an incremental trend for HPV-positive OPSCC over 18 years. HPV16 alone was found in 76.9%, and HPV58 in 7.5% tumors.Among males more tumors were HPV-negative than positive, but among the 34 females more tumors were HPV-positive (62% vs. 38%, p < 0.0001), more commonly from the tonsils (p < 0.01), and less prone to use tobacco, alcohol, and betel quid (p < 0.0001).For all patients, HPV-positive OPSCC was associated with higher age at diagnosis (55.5 vs. 52.7 years, p = 0.004), and lower T-stage (p = 0.02). HPV-positivity in OPSCC tumors was an independent predictor of better overall survival (OS) (hazard ratio [HR] 0.57 [95% CI 0.41-0.80], p = 0.0009), and disease-free survival (DFS) (HR 0.53 [95% CI 0.40-0.72], p < 0.0001) in multivariable estimations for up to 5-year post-diagnosis. Alcohol consumption was strongly associated with higher risk of recurrence and death (OS: HR 2.02 [95% CI 1.52-2.68], p < 0.0001; DFS: HR 1.70 [95% CI 1.31-2.21], p < 0.0001). No predictive associations were found for smoke or betel quid. Kaplan-Meier’s OS and DFS were longer in HPV-positive cases (p < 0.0001), but this advantage decreased for alcohol users (p < 0.0001). Lastly, HPV-positive OPSCC had the best outcomes in non-drinkers, non-smokers, and non-betel quid chewers, but the prognostic benefit of HPV persisted in the presence of these risk factors.Conclusions Consistent with the increasing role of HPV on OPSCC globally, HPV is an important etiological factor in more than one-fourth of OPSCC cases from Chang Gung Hospital. Like in Western countries, HPV provides considerable independent survival benefits to OPSCC, but the added prognostic value is reduced by exposure to the risk factors, alcohol, smoking, and betel quid. There is a need to consider HPV as an etiologic factor in treatment and in cancer-prevention policies in Taiwan.Why was this study done?Oropharyngeal squamous cell carcinoma (OPSCC) caused by human papillomavirus (HPV) has been increasing with epidemic proportions in North America and West Europe during the last 40 years. Socioeconomic changes have propelled the advance of this disease, and transformation from the classic etiology of OPSCC, alcohol, and tobacco, to HPV.Contrarily, in Taiwan, OPSCC has been drastically increasing due to persistent heavy consumption of alcohol, smoking, and betel quid chewing, limiting the understanding of HPV contribution to OPSCC. This study investigated the role of HPV in OPSCC in Taiwan.What did the researchers do and find?We conducted a comprehensive retrospective cohort study for 541 OPSCC cases diagnosed between 1998-2016 at the Chang Gung Memorial Hospital-Linkou, Taiwan.We found that OPSCCs mostly occurred in men (94%) and risk factors, including use of alcohol, tobacco, and betel quid was high (87%).Active HPV was present in 28.4% of the cases, 25% of tumors from males and 62% of tumors from females were HPV-positive. HPV16 was the most prevalent genotype (76.9%), followed by HPV58 (7.5%).Most of the HPV-positive OPSCCs originated in the tonsils, and females were less likely to abuse alcohol, tobacco, and betel quid than the males.Furthermore, outcome analysis showed that for the whole cohort, HPV positivity was associated with significantly better OPSCC survival. Alcohol was a strong negative prognostic factor. The robust prognostic benefit of HPV persisted in the presence of all other risk factors.What do these findings mean?HPV is an important emerging etiologic factor of OPSCC in Taiwan, and an independent predictor for better prognosis.The strong association of HPV with OPSCC over a period of 18 years suggests that societal behavioral changes are occurring; and, that there is a potential for benefit from interventions to improve treatment and prevent HPV-positive OPSCC in Taiwan and South-East Asia.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThis study was funded by the University of Michigan-Chang Gung Memorial Hospital Pilot Grant (https://www.rogelcancercenter.org and https://www.cgmh.org.tw/en) to K-PC and TEC; the National Cancer Institute at the National Institutes of Health (https://www.cancer.gov), CA194536 to TEC and HMW, and CA194536-S1 to GLH; the Chang Gung Memorial Hospital, CMRPG3H0852, CMRPG3J1251, and CORPG3G0171 to K-PC; the Taiwan Ministry of Science and Technology (https://www.most.gov.tw), MOST 108-2314-B-182A-108-MY3 to K-PC; and, funds from the University of Michigan Undergraduate Research Opportunity Program (https://lsa.umich.edu/urop) to GLH, TEC and HMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This retrospective study was approved by the Institutional Review Boards of the University of Michigan Medical School and the Chang Gung Memorial Hospital and conducted in compliance with the ethical guidelines of the World Medical Association's Declaration of Helsinki (1964, amended in 2013) and local regulations. Additional patient consent was not required by the institutional review boards as this OPSCC cohort comprised secondary use of tissue specimens with unidentified chart data. The procedures described in this manuscript followed the reporting standards for human subject research of the EQUATOR Network, which are detailed in the STROBE report for this study (S1 Checklist).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are included in this manuscript and its Supporting Information, excepting sensitive data that could allow the identification of the patients in this study. The full data set is available upon request to the senior authors and approval of ethical and legal agreements.CGMHChang Gung Memorial HospitalDFSdisease-free survivalEQUATOREnhancing the QUAlity and Transparency Of health Research NetworkFFPEformalin-fixed paraffin-embeddedHPVhuman papillomavirushrHPVhigh-risk human papillomavirusIHCimmunohistochemical stainingOSoverall survivalOPSCCoropharyngeal squamous cell carcinomaPCR-MAmultiplex PCR-MassArraySTROBEStrengthening the Reporting of Observational Studies in Epidemiology.